Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

Author(s):
Zunder, S.; Pelt, G. van; Gelderblom, H.; Tollenaar, R.; Mancao, C.; Mesker, W.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-30
Language
English
Is part of
Annals of Oncology
hdl
1887/95246